Sep 13, 2022 / 03:10PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
All right. Thanks, everyone, for joining. Appreciate it. Let's go ahead and get started. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research. Happy to have with me on the stage Theravance Biopharma.
Let me read a quick disclosure statement before we get started. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
With that, happy to have with me Rick Winningham, CEO; Andrew Hindman, CFO; and Rhonda Farnum. Thank you for joining us. Appreciate it.
Rick E. Winningham - Theravance Biopharma, Inc. - Chairman & CEO
Happy to be here.
Questions and Answers:
Vikram Purohit - Morgan Stanley, Research Division - Equity AnalystRick, maybe